Clinical Trials

While BIG is mainly focused on large adjuvant trials, it also provides a discussion forum for prevention trials and studies in advanced breast cancer. In general, a minimum of two cooperative groups that are BIG members must commit to a study in order for it to become a BIG trial, although in most cases, three or more groups are involved. One of these becomes the designated coordinating group. While a pharmaceutical company usually supports the large adjuvant studies, trials without industry backing are strongly encouraged.

Latest News

BIG Annual Report 2008 available

The BIG Annual Report for 2008 describes a year of evolution and chan...

IMPAKT 2009 Outcomes

Webcast and book of abstracts now available

Upcoming Events 

20/09/2009
06/05/2010

Newsletter subscription